Literature DB >> 9564470

Burkholderia pseudomallei infection in a Puerto Rican patient with chronic granulomatous disease: case report and review of occurrences in the Americas.

S E Dorman1, V J Gill, J I Gallin, S M Holland.   

Abstract

Burkholderia species, notably Burkholderia cepacia and Burkholderia gladioli, are important pathogens in patients with chronic granulomatous disease (CGD). Burkholderia pseudomallei, the causative agent of melioidosis, is endemic in Southeast Asia and northern Australia but is a rare pathogen in other parts of the world. We describe the occurrence of B. pseudomallei infection in a Puerto Rican patient with CGD. This is one of only a small number of documented cases of melioidosis autochthonous to the Americas and is the first reported case of B. pseudomallei infection in a CGD patient from the Americas. We conclude that B. pseudomallei, like B. cepacia and B. gladioli, should be considered a potential pathogen in patients with CGD and that melioidosis should be considered in the differential diagnosis for ill residents of or travelers to Puerto Rico.

Entities:  

Mesh:

Year:  1998        PMID: 9564470     DOI: 10.1086/513928

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  29 in total

Review 1.  Chronic granulomatous disease.

Authors:  D Goldblatt; A J Thrasher
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

Review 2.  Environmental factors that affect the survival and persistence of Burkholderia pseudomallei.

Authors:  Timothy J J Inglis; Jose-Luis Sagripanti
Journal:  Appl Environ Microbiol       Date:  2006-09-15       Impact factor: 4.792

3.  Burkholderia pseudomallei infection in chronic granulomatous disease.

Authors:  Raffaele Renella; Jean-Marie Perez; Sylvie Chollet-Martin; Sabine Sarnacki; Alain Fischer; Stéphane Blanche; Jean-Laurent Casanova; Capucine Picard
Journal:  Eur J Pediatr       Date:  2005-12-03       Impact factor: 3.183

4.  Genetic tools for allelic replacement in Burkholderia species.

Authors:  Ashley R Barrett; Yun Kang; Ken S Inamasu; Mike S Son; Joseph M Vukovich; Tung T Hoang
Journal:  Appl Environ Microbiol       Date:  2008-05-23       Impact factor: 4.792

Review 5.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

Review 6.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

7.  Infection Profile in Chronic Granulomatous Disease: a 23-Year Experience from a Tertiary Care Center in North India.

Authors:  Amit Rawat; Pandiarajan Vignesh; Avinash Sharma; Jitendra K Shandilya; Madhubala Sharma; Deepti Suri; Anju Gupta; Vikas Gautam; Pallab Ray; Shivaprakash M Rudramurthy; Arunaloke Chakrabarti; Kohsuke Imai; Shigeaki Nonoyama; Osamu Ohara; Yu L Lau; Surjit Singh
Journal:  J Clin Immunol       Date:  2017-03-22       Impact factor: 8.317

8.  The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study.

Authors:  Bart J Currie; Linda Ward; Allen C Cheng
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

9.  Characterization of BcaA, a putative classical autotransporter protein in Burkholderia pseudomallei.

Authors:  Cristine G Campos; Luke Borst; Peggy A Cotter
Journal:  Infect Immun       Date:  2013-01-22       Impact factor: 3.441

10.  Phagocyte NADPH oxidase, but not inducible nitric oxide synthase, is essential for early control of Burkholderia cepacia and chromobacterium violaceum infection in mice.

Authors:  Brahm H Segal; Li Ding; Steven M Holland
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.